Abstract

BackgroundInfants born HIV-exposed yet remain uninfected (HEU) are at increased risk of poorer growth and health compared to infants born HIV-unexposed (HU). Whether maternal antiretroviral treatment (ART) in pregnancy ameliorates this risk of poorer growth is not well understood. Furthermore, whether risks are similar across high burden HIV settings has not been extensively explored.MethodsWe harmonized data from two prospective observational studies conducted in Cape Town, South Africa, and Lusaka, Zambia, to compare weight-for-age (WAZ), length-for-age (LAZ) and weight-for-length (WLZ) Z-scores between infants who were HEU and HU, converting infant anthropometric measures using World Health Organisation Growth Standards adjusted for age and sex. Linear mixed effects models were fit to identify risk factors for differences in anthropometrics at 6–10 weeks and 6 months by infant HIV exposures status and by timing of exposure to maternal ART, either from conception or later in gestation.ResultsOverall 773 mother-infant pairs were included across two countries: women living with HIV (WLHIV), 51% (n = 395) with 65% on ART at conception and 35% initiating treatment in pregnancy. In linear mixed effects models, WAZ and WLZ at 6–10 weeks were lower among infants who were HEU vs HU [β = − 0.29 (95% CI: − 0.46, − 0.12) and [β = − 0.42 (95% CI: − 0.68, − 0.16)] respectively after adjusting for maternal characteristics and infant feeding with a random intercept for country. At 6 months, LAZ was lower [β = − 0.28 CI: − 0.50, − 0.06)] among infants who were HEU, adjusting for the same variables, with no differences in WAZ and WLZ. Within cohort evaluations identified different results with higher LAZ among infants who were HEU from Zambia at 6–10 weeks, [β = + 0.34 CI: + 0.01, + 0.68)] and lower LAZ among infants who were HEU from South Africa [β = − 0.30 CI: − 0.59, − 0.01)] at 6 months, without other anthropometric differences at either site.ConclusionInfant growth trajectories differed by country, highlighting the importance of studying contextual influences on outcomes of infants who were HEU.

Highlights

  • Scale-up of maternal antiretroviral treatment (ART) use in pregnancy to prevent vertical HIV transmission has been one of the most successful global publicNyemba et al BMC Public Health (2022) 22:55 health programs

  • An unprecedented number of women are taking ART at conception and during pregnancy with over 1 million women living with HIV (WLHIV) giving birth annually [1]

  • While vertical HIV transmission prevention programs have improved the health of women living with HIV and averted infant HIV acquisition, infants who are HIV exposed but uninfected (HEU) experience a higher risk of poor health outcomes compared to infants who are HIV-unexposed (HU)

Read more

Summary

Introduction

Scale-up of maternal antiretroviral treatment (ART) use in pregnancy to prevent vertical HIV transmission has been one of the most successful global publicNyemba et al BMC Public Health (2022) 22:55 health programs. An unprecedented number of women are taking ART at conception and during pregnancy with over 1 million women living with HIV (WLHIV) giving birth annually [1] This success has dramatically reduced the number of infants who acquire HIV, contributing to a large and growing population of infants with in-utero dual exposure to HIV and antiretroviral (ARV) drugs [2]. Several studies have reported that infants who are HEU experience poorer growth, health and survival outcomes compared to infants who are HU, starting from birth [2,3,4,5,6,7,8,9] This has brought into question the extent to which fetal exposure to ARVs and the duration of exposure, either from conception or at a later period of gestation, may be contributing to this disparity. Whether risks are similar across high bur‐ den HIV settings has not been extensively explored

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call